Overview Fundamentals API Earnings EOD API Sample Code Pricing

Annexon Inc (ANNX NASDAQ) stock market data APIs

$5.74 -0.13(-2.2%) as of July 23, 2024
Price chart is built with Anychart

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Annexon Inc Financial Data Overview

614 M
105 M
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ANNX',
Type: 'Common Stock',
Name: 'Annexon Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG007QVDFG2',
CIK: '1528115',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-07-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Annexon Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -128 903 000
  • Earnings Per Share -1.46
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Annexon Inc Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.34

Get Annexon Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?